Immunovant Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $405.8M
Liabilities Breakdown FY2023
Total Liabilities: $43.3M
Asset Breakdown
Total Assets: $405.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $376.5M | 92.8% |
| Accounts Receivable | $700.0K | 0.2% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $333.0K | 0.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $28.3M | 7.0% |
Liabilities Breakdown
Total Liabilities: $43.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.4M | 3.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $42.0M | 96.9% |